HomeINDUSTRY EXPERT ARTICLES

INDUSTRY EXPERT ARTICLES

Increases in Home Delivery and the Growth of Major Shippers Highlight 2024 Trends | By Tim McClatchy, Head of Life Sciences, Kenco

The growth of in-home care along with technology improvements like AI are shifting how medical device companies manage their inventory and final-mile deliveries. This, coupled by the increase of innovations like robotic-assisted surgeries, is creating a lasting impact on the medical devices supply chain. In fact, the healthcare third-party logistics (3PL) market is expected to grow at a compound annual growth rate of 7.6% from 2023 to 2030.

AI and the Human Touch: Embracing a Symbiotic Future | By Ed Watal, Founder & Principal — Intellibus

Watal writes, "Today, we see machines becoming more intelligent and capable than humans in many areas, from driving cars to diagnosing diseases. AI solves problems we cannot even approach, and it's getting better every day — but what does this mean for us? 

It’s Time to Move Beyond Mere Patient Navigation | By Craig Parker, JD, CPA and CEO, Guideway Care

Parker writes, "Is your patient navigation program delivering the outcomes you desire? Consider the following questions as you evaluate your current program. Read on.

Transforming Hammertoe Procedures: Forma Medical’s OptimalHT Revolutionizes MIS Hammertoe Arthrodes | By Andrew C. Davison

As the President and CEO of Forma Medical, I am excited to share how our groundbreaking approach, known as OptimalHT, is set to revolutionize hammertoe treatment. Our mission at Forma Medical has always been clear: to enhance the lives of patients by providing innovative surgical solutions. Today, I want to take you on a journey through the challenges of hammertoe deformities, the birth of OptimalHT, its key benefits, and our commitment to advancing surgery.

A Platform Approach: Expanding a Molecular Diagnostic Device Beyond Human Applications | By Shaun Holt, CEO, Alveo Technologies

Holt writes, "Avian flu is a global crisis, and not just for the poultry industry. There are serious potential implications for human health as well. But, let’s start with agriculture. Some strains of avian flu can be highly pathogenic. Once a single bird shows symptoms the clock starts ticking — it’s not unusual for an entire flock of tens of thousands of birds to die within two to three days."

The Hollywood Writers’ Strike and Ethical AI | By Ed Watal, Founder & Principal — Intellibus

Watal writes, "Less than 12 months ago, with the debut of AI-powered ChatGPT, the true power of AI hit the mainstream. Since then, it has established an unshakeable belief in everyone’s minds that artificial intelligence is here to stay and will forever alter a number of industries." What do you think? Read on.

Viraj Gandhi On Automation and Technology – to Drive Progress in Pharmaceutical Manufacturing

This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.

Limb Loss and Preservation Registry (LLPR) Transforms Care Through Data and Insights | By Shawn Murphy, Vice President, Thought Leadership & Innovation Foundation...

Shawn Murphy writes, "The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality." Read to learn more.

It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty...

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.
Exit mobile version